中枢神经系统疾病基因治疗面临的挑战及对帕金森病治疗的启示。 - Suppr

Suppr

超能文献

Challenges for gene therapy of CNS disorders and implications for Parkinson's disease therapies.

作者信息

Broadstock Martin, Yáñez-Muñoz Rafael J

机构信息

Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London, London SE1 1UL, United Kingdom.

出版信息

Hum Gene Ther. 2012 Apr;23(4):340-3. doi: 10.1089/hum.2012.2507. Epub 2012 Apr 10.

DOI:10.1089/hum.2012.2507

PMID:22490128

Abstract

摘要

相似文献

Challenges for gene therapy of CNS disorders and implications for Parkinson's disease therapies.

Hum Gene Ther. 2012 Apr;23(4):340-3. doi: 10.1089/hum.2012.2507. Epub 2012 Apr 10.

Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

Mol Ther. 2001 Oct;4(4):324-30. doi: 10.1006/mthe.2001.0466.

[Gene therapy for Parkinson's disease].

Nihon Rinsho. 2005 Dec;63 Suppl 12:622-5.

Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease.

Neurosurgery. 2010 Nov;67(5):1377-85. doi: 10.1227/NEU.0b013e3181f53a5c.

[Advances in the application of gene therapy for Parkinson's disease with adeno-associated virus].

Yao Xue Xue Bao. 2014 May;49(5):576-81.

[Prospects on gene therapy of Parkinson disease].

Nihon Naika Gakkai Zasshi. 1998 Jun 10;87(6):1149-54.

[Present status and future prospects for gene therapy in Parkinson's disease].

Nihon Naika Gakkai Zasshi. 2003 Aug 10;92(8):1461-6.

Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.

Hum Gene Ther. 2000 Jul 20;11(11):1509-19. doi: 10.1089/10430340050083243.

Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.

Hum Gene Ther. 2002 Feb 10;13(3):345-54. doi: 10.1089/10430340252792486.

Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.

Hum Gene Ther. 2012 Apr;23(4):377-81. doi: 10.1089/hum.2011.220. Epub 2012 Apr 10.

引用本文的文献

Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease.

Genes (Basel). 2021 Nov 22;12(11):1840. doi: 10.3390/genes12111840.

Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy.

Viruses. 2014 Aug 21;6(8):3293-310. doi: 10.3390/v6083293.

Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.

Hum Gene Ther. 2014 Jul;25(7):631-41. doi: 10.1089/hum.2014.003. Epub 2014 Apr 15.

CSSI workshop in Brazil highlights "Stress Responses in the Nervous System" in relation to neurodegenerative diseases and neuroprotection.

Cell Stress Chaperones. 2012 Nov;17(6):657-60. doi: 10.1007/s12192-012-0366-y. Epub 2012 Aug 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验